Glycorex Transplantation AB (publ) (FRA:O33)

Germany · Delayed Price · Currency is EUR

0.0976

-0.0034 (-3.37%)

Last updated: Aug 27, 2026, 8:01 AM CET

-44.23% (1Y)

Market Cap	9.52M -37.4%
Revenue (ttm)	3.46M +3.4%
Net Income	-873.06K
EPS	-0.01
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0976
Previous Close	0.1010
Day's Range	0.0976 - 0.0976
52-Week Range	0.0206 - 0.2430
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About FRA:O33

Glycorex Transplantation AB (publ), a medical technology company, research, develops, manufactures, markets, and sells products in the field of organ transplantation or related areas. It develops an antigen-specific immunoadsorption to reduce blood group antibodies and autoantibodies in the blood. The company’s principal product is Glycosorb-ABO, which enables blood group incompatible kidney transplantation and is also used to enable heart, liver, lung, and stem cell transplantation procedures. It serves in the United Kingdom, Australia, Scandi...

Industry Surgical and Medical Instruments and Apparatus

Founded 1995

Employees 20

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol O33